Drawing for TRUNAV

USPTO serial 97718671

TRUNAV

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KENEALY, NATALIE LANGFORD
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with TRUNAV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Constance B. Stefanou

Constance B. Stefanou MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
010Medical diagnostic blood testing apparatus for use in the field of coronary artery disease; Medical test kits in the field of coronary artery disease consisting primarily of a blood collection tube containing a preservative, a set of reagents for purifying RNA, a set of primers and probes for quantifying transcript levels, and related downloadable or recorded computer software featuring an algorithm for computing risk of coronary artery disease sold as a unit for home use and for use by medical practitioners in the diagnosis of Atherosclerotic burden; medical devices for diagnosing coronary artery diseaseACTIVE—
042Research services in the field of medicine, namely, scientific research services and medical researchACTIVE—
044Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, Atherosclerotic load risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing guidance for hypercholesterolemia treatment; medical analysis for the treatment of coronary artery disease (CAD); healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 20, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 23, 2026EXT5SOU EXTENSION 5 FILED—
Jun 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 18, 2025EX4GSOU EXTENSION 4 GRANTED—
Dec 18, 2025EXT4SOU EXTENSION 4 FILED—
Dec 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2025EX3GSOU EXTENSION 3 GRANTED—
Jun 25, 2025EXT3SOU EXTENSION 3 FILED—
Jun 25, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 24, 2024EX2GSOU EXTENSION 2 GRANTED—
Dec 24, 2024EXT2SOU EXTENSION 2 FILED—
Dec 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 28, 2024EX1GSOU EXTENSION 1 GRANTED—
May 28, 2024EXT1SOU EXTENSION 1 FILED—
May 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 21, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 21, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 21, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 19, 2023DOCKASSIGNED TO EXAMINER—
Jan 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance